174 related articles for article (PubMed ID: 34658851)
1. Lysophosphatidic Acid-Induced EGFR Transactivation Promotes Gastric Cancer Cell DNA Replication by Stabilizing Geminin in the S Phase.
Zhao H; Gezi G; Tian X; Jia P; Morigen M; Fan L
Front Pharmacol; 2021; 12():706240. PubMed ID: 34658851
[TBL] [Abstract][Full Text] [Related]
2. Lysophosphatidic acid suppresses apoptosis of high-grade serous ovarian cancer cells by inducing autophagy activity and promotes cell-cycle progression
Zhao H; Jia P; Nanding K; Wu M; Bai X; Morigen M; Fan L
Front Pharmacol; 2022; 13():1046269. PubMed ID: 36601056
[TBL] [Abstract][Full Text] [Related]
3. Regulation of lysophosphatidic acid-induced epidermal growth factor receptor transactivation and interleukin-8 secretion in human bronchial epithelial cells by protein kinase Cdelta, Lyn kinase, and matrix metalloproteinases.
Zhao Y; He D; Saatian B; Watkins T; Spannhake EW; Pyne NJ; Natarajan V
J Biol Chem; 2006 Jul; 281(28):19501-11. PubMed ID: 16687414
[TBL] [Abstract][Full Text] [Related]
4. Lysophosphatidic acid induces both EGFR-dependent and EGFR-independent effects on DNA synthesis and migration in pancreatic and colorectal carcinoma cells.
Tveteraas IH; Aasrum M; Brusevold IJ; Ødegård J; Christoffersen T; Sandnes D
Tumour Biol; 2016 Feb; 37(2):2519-26. PubMed ID: 26386720
[TBL] [Abstract][Full Text] [Related]
5. TNF-α and LPA promote synergistic expression of COX-2 in human colonic myofibroblasts: role of LPA-mediated transactivation of upregulated EGFR.
Yoo J; Rodriguez Perez CE; Nie W; Sinnett-Smith J; Rozengurt E
BMC Gastroenterol; 2013 May; 13():90. PubMed ID: 23688423
[TBL] [Abstract][Full Text] [Related]
6. Lysophosphatidic acid-induced squamous cell carcinoma cell proliferation and motility involves epidermal growth factor receptor signal transactivation.
Gschwind A; Prenzel N; Ullrich A
Cancer Res; 2002 Nov; 62(21):6329-36. PubMed ID: 12414665
[TBL] [Abstract][Full Text] [Related]
7. Lysophosphatidic acid promoting corneal epithelial wound healing by transactivation of epidermal growth factor receptor.
Xu KP; Yin J; Yu FS
Invest Ophthalmol Vis Sci; 2007 Feb; 48(2):636-43. PubMed ID: 17251460
[TBL] [Abstract][Full Text] [Related]
8. The Cdk2-c-Myc-miR-571 Axis Regulates DNA Replication and Genomic Stability by Targeting Geminin.
Zhang Y; Li Z; Hao Q; Tan W; Sun J; Li J; Chen CW; Li Z; Meng Y; Zhou Y; Han Z; Pei H; DePamphilis ML; Zhu W
Cancer Res; 2019 Oct; 79(19):4896-4910. PubMed ID: 31431461
[TBL] [Abstract][Full Text] [Related]
9. Proteolysis of DNA replication licensing factor Cdt1 in S-phase is performed independently of geminin through its N-terminal region.
Nishitani H; Lygerou Z; Nishimoto T
J Biol Chem; 2004 Jul; 279(29):30807-16. PubMed ID: 15138268
[TBL] [Abstract][Full Text] [Related]
10. Lysophosphatidic acid-induced transactivation of epidermal growth factor receptor regulates cyclo-oxygenase-2 expression and prostaglandin E(2) release via C/EBPbeta in human bronchial epithelial cells.
He D; Natarajan V; Stern R; Gorshkova IA; Solway J; Spannhake EW; Zhao Y
Biochem J; 2008 May; 412(1):153-62. PubMed ID: 18294142
[TBL] [Abstract][Full Text] [Related]
11. Characterization of conserved arginine residues on Cdt1 that affect licensing activity and interaction with Geminin or Mcm complex.
You Z; Ode KL; Shindo M; Takisawa H; Masai H
Cell Cycle; 2016 May; 15(9):1213-26. PubMed ID: 26940553
[TBL] [Abstract][Full Text] [Related]
12. Re-replication induced by geminin depletion occurs from G2 and is enhanced by checkpoint activation.
Klotz-Noack K; McIntosh D; Schurch N; Pratt N; Blow JJ
J Cell Sci; 2012 May; 125(Pt 10):2436-45. PubMed ID: 22366459
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical assessment of chromatin licensing and DNA replication factor 1, geminin, and γ-H2A.X in oral epithelial precursor lesions and squamous cell carcinoma.
Siril YJ; Kouketsu A; Oikawa M; Takahashi T; Kumamoto H
J Oral Pathol Med; 2019 Nov; 48(10):888-896. PubMed ID: 31318980
[TBL] [Abstract][Full Text] [Related]
14. Lysophosphatidic acid-induced effects in human colon carcinoma DLD1 cells are partially dependent on transactivation of epidermal growth factor receptor.
Mori K; Kitayama J; Shida D; Yamashita H; Watanabe T; Nagawa H
J Surg Res; 2006 May; 132(1):56-61. PubMed ID: 16289596
[TBL] [Abstract][Full Text] [Related]
15. Lysophosphatidic acid 5 receptor induces activation of Na(+)/H(+) exchanger 3 via apical epidermal growth factor receptor in intestinal epithelial cells.
Yoo BK; He P; Lee SJ; Yun CC
Am J Physiol Cell Physiol; 2011 Nov; 301(5):C1008-16. PubMed ID: 21832242
[TBL] [Abstract][Full Text] [Related]
16. Human geminin promotes pre-RC formation and DNA replication by stabilizing CDT1 in mitosis.
Ballabeni A; Melixetian M; Zamponi R; Masiero L; Marinoni F; Helin K
EMBO J; 2004 Aug; 23(15):3122-32. PubMed ID: 15257290
[TBL] [Abstract][Full Text] [Related]
17. GPR87 mediates lysophosphatidic acid-induced colony dispersal in A431 cells.
Ochiai S; Furuta D; Sugita K; Taniura H; Fujita N
Eur J Pharmacol; 2013 Sep; 715(1-3):15-20. PubMed ID: 23831392
[TBL] [Abstract][Full Text] [Related]
18. Galardin (GM 6001), a broad-spectrum matrix metalloproteinase inhibitor, blocks bombesin- and LPA-induced EGF receptor transactivation and DNA synthesis in rat-1 cells.
Santiskulvong C; Rozengurt E
Exp Cell Res; 2003 Nov; 290(2):437-46. PubMed ID: 14568001
[TBL] [Abstract][Full Text] [Related]
19. Lysophosphatidic acid decreases epidermal growth factor receptor binding in airway epithelial cells.
Kassel KM; Schulte NA; Parker SM; Lanik AD; Toews ML
J Pharmacol Exp Ther; 2007 Oct; 323(1):109-18. PubMed ID: 17640953
[TBL] [Abstract][Full Text] [Related]
20. DUB3 and USP7 de-ubiquitinating enzymes control replication inhibitor Geminin: molecular characterization and associations with breast cancer.
Hernández-Pérez S; Cabrera E; Salido E; Lim M; Reid L; Lakhani SR; Khanna KK; Saunus JM; Freire R
Oncogene; 2017 Aug; 36(33):4802-4809. PubMed ID: 28288134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
